US Stock MarketDetailed Quotes

BHVN Biohaven

Watchlist
  • 42.160
  • -1.870-4.25%
Close Apr 18 16:00 ET
  • 41.560
  • -0.600-1.42%
Post 19:15 ET
3.44BMarket Cap-7357P/E (TTM)

About Biohaven Company

Biohaven Ltd. is a global clinical stage biopharmaceutical company, which engages in the discovery, development, and commercialization of therapies for people with neurological and neuropsychiatric diseases. The company was founded on May 2, 2022 and is headquartered in New Haven, CT.

Company Profile

SymbolBHVN
Company NameBiohaven
Listing DateMay 4, 2017
Issue Price17.00
Founded2022
CEODr. Vlad Coric, M.D.
MarketNYSE
Employees239
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address215 Church Street
CityNew Haven
ProvinceConnecticut
CountryUnited States of America
Zip Code06510
Phone1-203-404-0410
Websitehttp://www.biohaven.com

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Vlad Coric, M.D.
  • Chief Executive Officer and Chairman of the Board
  • 6.82M
  • Matthew Buten
  • Chief Financial Officer
  • 2.76M
  • Bruce Car
  • Chief Scientific Officer
  • 2.58M
  • George C. Clark
  • Chief Accounting Officer and Vice President
  • --
  • Kimberly Gentile
  • Senior Vice President, Clinical Operations
  • 2.56M
  • Kishan Mehta
  • Director
  • 535.94K
  • Dr. Irina Antonijevic, M.D.
  • Independent Director
  • 542.94K
  • Robert J. Hugin
  • Independent Director
  • 562.94K
  • Michael T. Heffernan, R.Ph.
  • Lead Independent Director
  • 597.94K
  • John W. Childs
  • Independent Director
  • 555.94K
  • Dr. Gregory Hugh Bailey, M.D.
  • Independent Director
  • 545.94K
  • Julia P. Gregory
  • Independent Director
  • 567.94K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg